Hyperlipidaemia and Skin atrophy

Summary:

Skin atrophy is found among people with Hyperlipidaemia, especially for people who are female, 60+ old.

The study analyzes which people have Skin atrophy with Hyperlipidaemia. It is created by eHealthMe based on reports of 12 people who have Hyperlipidaemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hyperlipidaemia?

Hyperlipidaemia (presence of excess lipids in the blood) is found to be associated with 1,426 drugs and 1,407 conditions by eHealthMe. Check the latest studies of Hyperlipidaemia.

What is Skin atrophy?

Skin atrophy (wasting of skin) is found to be associated with 624 drugs and 716 conditions by eHealthMe. Check the latest studies of Skin atrophy.



On Jul, 27, 2026

12 people who have Hyperlipidaemia and Skin Atrophy are studied.

Would you have Skin atrophy when you have Hyperlipidaemia?

Gender of people who have Hyperlipidaemia and experienced Skin Atrophy *:

  • female: 83.33 %
  • male: 16.67 %

Age of people who have Hyperlipidaemia and experienced Skin Atrophy *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 44.44 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 55.56 %

Common co-existing conditions for these people *:

  1. High Blood Cholesterol: 4 people, 33.33%
  2. Osteoporosis (bones weak and more likely to break): 4 people, 33.33%
  3. Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 4 people, 33.33%
  4. Diabetes: 4 people, 33.33%
  5. Pain: 3 people, 25.00%
  6. Depression: 3 people, 25.00%
  7. Hypersensitivity: 2 people, 16.67%
  8. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 16.67%
  9. Abdominal Pain Upper: 1 person, 8.33%
  10. Anaemia Folate Deficiency (lack of blood due to deficiency of folate): 1 person, 8.33%

Common drugs taken by these people *:

  1. Praluent: 5 people, 41.67%
  2. Alendronate Sodium: 4 people, 33.33%
  3. Neoral: 4 people, 33.33%
  4. Humulin R: 4 people, 33.33%
  5. Lasix: 4 people, 33.33%
  6. Slow-K: 4 people, 33.33%
  7. Prednisolone: 4 people, 33.33%
  8. Locholest: 4 people, 33.33%
  9. Lipitor: 3 people, 25.00%
  10. Livalo: 2 people, 16.67%

Common symptoms for these people *:

  1. Head Injury: 6 people, 50.00%
  2. Purpura (purplish discoloration of the skin): 6 people, 50.00%
  3. Abdominal Pain: 5 people, 41.67%
  4. Anaemia (lack of blood): 5 people, 41.67%
  5. Large Intestine Perforation (hole in large intestine): 4 people, 33.33%
  6. Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 4 people, 33.33%
  7. White Blood Cell Count Increased: 4 people, 33.33%
  8. Impaired Healing: 4 people, 33.33%
  9. Hypotension (abnormally low blood pressure): 4 people, 33.33%
  10. Heart Rate Increased: 4 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Skin atrophy?

- Check whether Skin atrophy is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Skin atrophy:

All the conditions that are associated with Skin atrophy:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Skin atrophy and Hyperlipidaemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: